Perinatal induction of hepatic aminopyrine N-demethylase by maternal exposure to phenytoin
Shapiro, B.H.; Bardales, R.M.; Lech, G.M.
Pediatric Pharmacology 5(3): 201-207
1985
ISSN/ISBN: 0270-322X PMID: 4094815 Document Number: 261941
Phenytoin is one of the most commonly used anticonvulsants in pregnant epileptic women. Unrelatedly, the drug is also an inducer of hepatic drug metabolizing enzymes. We report here that maternal treatment with therapeutic-like doses for the rat of phenytoin produces significant elevations in the Michaelis constants and maximal velocities of hepatic aminopyrine N-demethylase in the dams' 8-day-old offspring. Although the drug apparently had little, if any, adverse effects on the course of pregnancy or neonatal development, it appears that the maternally administered phenytoin was transferred to the perinates where it induced hepatic drug metabolizing enzymes.
Document emailed within 1 workday
Related Documents
Chan, H.H.; Buhler, D.R. 1984: Comparison of nitrosocarbaryl and carbaryl: in vitro effects on hepatic microsomal aryl hydrocarbon hydroxylase, aminopyrine N-demethylase, epoxide hydrolase and cytosolic glutathione-S-transferase Proceedings of the National Science Council Republic of China. Part B Life Sciences 8(4): 302-307Bauer, C.; Cercignani, G.; Gervasi, P.G.; Stretti, G.; Turchi, G.; Di Natale, G. 1977: Notes on the determination of the aminopyrine demethylase activity in liver microsomes. II. Effect of semicarbazide Bollettino della Societa Italiana di Biologia Sperimentale 53(22): 2156-2158
Iakushko, V.E.; Zlatev, Z.D. 1975: Toxicity of some acaricides and the change in liver microsomal aminopyrine demethylase activity under conditions of their combined and separate use Gigiena Truda i Professional'nye Zabolevaniya (9): 55-57
Soyka, L.F. 1980: Hepatic drug metabolizing enzyme activity and tumorigenesis in mice following perinatal exposure to benzo(a)pyrene Pediatric Pharmacology 1(1): 85-96
Sensing, H.; Haustein, K.O.; Hüller, G. 1983: Hepatic clearance of aminopyrine in the evaluation of liver function in hormonal contraception Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 38(23): 622-626
Bae, W.H.; Wester, C.; Smeaton, L.M.; Shapiro, R.L.; Lockman, S.; Onyait, K.; Thior, I.; Essex, M. 2008: Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants Aids 22(13): 1633-1640
Filipowicz, C.; McCauley, R. 1986: The effect of chronic ozone exposure on lung benzo(a)pyrene oxidase, benzphetamine demethylase and monoamine oxidase Research Communications in Chemical Pathology and Pharmacology 51(3): 289-296
Miller, R.; Bill, P.L.; Du Toit, J. 1989: Phenytoin auto-induction? Case reports South African Medical Journal 75(7): 332-333
Pattinson, R.C.; Hulsbergen, M.H.; Van Hoorick, L. 2010: The effect of maternal HIV infection on maternal conditions and perinatal deaths in southwest Tshwane Facts Views and Vision in Obgyn 2(4): 227-231
Dickover, R.E.; Garratty, E.M.; Herman, S.A.; Sim, M.S.; Plaeger, S.; Boyer, P.J.; Keller, M.; Deveikis, A.; Stiehm, E.R.; Bryson, Y.J. 1996: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load JAMA 275(8): 599-605
Siberry, G.K.; Patel, K.; Bellini, W.J.; Karalius, B.; Purswani, M.U.; Burchett, S.K.; Meyer, W.A.; Sowers, S.B.; Ellis, A.; Van Dyke, R.B.; Yogev, R.; Sanders, M.A.; Malee, K.; Hunter, S.; Shearer, W.; Paul, M.; Cooper, N.; Harris, L.; Purswani, M.; Baig, M.; Cintron, A.; Puga, A.; Navarro, S.; Garvie, P.; Blood, J.; Burchett, S.; Karthas, N.; Kammerer, B.; Wiznia, A.; Burey, M.; Nozyce, M.; Dieudonne, A.; Bettica, L.; Adubato, S.; Chen, J.; Bulkley, M.G.; Ivey, L.; Grant, M.; Knapp, K.; Allison, K.; Wilkins, M.; Acevedo-Flores, M.; Rios, H.; Olivera, V.; Silio, M.; Jones, M.; Sirois, P.; Spector, S.; Norris, K.; Nichols, S.; McFarland, E.; Katai, A.; Dunn, J.; Paul, S.; Scott, G.; Bryan, P.; Willen, E. 2015: Immunity to Measles, Mumps, and Rubella in US Children with Perinatal HIV Infection or Perinatal HIV Exposure Without Infection Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(6): 988-995
Althabe, F.; Moore, J.L.; Gibbons, L.; Berrueta, M.; Goudar, S.S.; Chomba, E.; Derman, R.J.; Patel, A.; Saleem, S.; Pasha, O.; Esamai, F.; Garces, A.; Liechty, E.A.; Hambidge, K.; Krebs, N.F.; Hibberd, P.L.; Goldenberg, R.L.; Koso-Thomas, M.; Carlo, W.A.; Cafferata, M.L.; Buekens, P.; McClure, E.M. 2015: Adverse maternal and perinatal outcomes in adolescent pregnancies: the Global Network's Maternal Newborn Health Registry study Reproductive Health 12(Suppl 2): S8
Thomas, P.A.; Weedon, J.; Krasinski, K.; Abrams, E.; Shaffer, N.; Matheson, P.; Bamji, M.; Kaul, A.; Hutson, D.; Grimm, K.T. 1994: Maternal predictors of perinatal human immunodeficiency virus transmission. the new York City Perinatal HIV Transmission Collaborative Study Group Pediatric Infectious Disease Journal 13(6): 489-495
Jariyapitaksakul, C.; Tannirandorn, Y. 2013: The occurrence of small for gestational age infants and perinatal and maternal outcomes in normal and poor maternal weight gain singleton pregnancies Journal of the Medical Association of Thailand 96(3): 259-265
Koblinsky, M. 2014: Reducing maternal and perinatal mortality through a community collaborative approach: introduction to a special issue on the Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) Journal of Midwifery and Women's Health 59 Suppl. 1: S1-S5
Tsuru, M.; Erickson, R.R.; Holtzman, J.L. 1982: The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats Journal of Pharmacology and Experimental Therapeutics 222(3): 658-661
Vogel, J.P.; Souza, J.P.; Mori, R.; Morisaki, N.; Lumbiganon, P.; Laopaiboon, M.; Ortiz-Panozo, E.; Hernandez, B.; Pérez-Cuevas, R.; Roy, M.; Mittal, S.; Cecatti, J.G.; Tunçalp, Ö; Gülmezoglu, A.M. 2014: Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health Bjog: An International Journal of Obstetrics and Gynaecology 121(Suppl 1): 76-88
Vogel, J.P.; Souza, J.P.; Mori, R.; Morisaki, N.; Lumbiganon, P.; Laopaiboon, M.; Ortiz-Panozo, E.; Hernandez, B.; Pérez-Cuevas, R.; Roy, M.; Mittal, S.; Cecatti, J.G.; Tunçalp, Ö; Gülmezoglu, A.M. 2014: Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health Bjog: An International Journal of Obstetrics and Gynaecology 121(Suppl 1): 76-88
Puche, E.; Garcia Morillas, M.; Garcia de la Serrana, H.; Mota, C. 1989: Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increased serum aspirin-esterase activity in epileptics International Journal of Clinical Pharmacology Research 9(5): 309-311
Ranney, B. 1972: II. Significant complications among obstetric patients. (Recognition and treatment of maternal complications. Associated perinatal mortality rates. Toxemia associated with obesity. Prematurity not associated with maternal urinary infections.) South Dakota Journal of Medicine 25(4): 13-21